Personal information

Activities

Collapse all

Employment (5)

Epizyme Inc: Cambridge, MA, US

2020-02-10 to present | Senior Scientist (Biological Sciences)
Employment
Source: Self-asserted source
Elizabeth W. Sorensen

Moderna Therapeutics Inc: Cambridge, MA, US

2018-08-06 to 2020-02-07 | Senior Scientist (Immunology)
Employment
Source: Self-asserted source
Elizabeth W. Sorensen

Massachusetts General Hospital: Boston, MA, US

2010-09 to 2018-05 | Post-Doctoral Fellow (Center for Immunology and Inflammatory Diseases)
Employment
Source: Self-asserted source
Elizabeth W. Sorensen

Pfizer Global Research and Development: Groton, CT, US

2003-05 to 2003-08 | Summer Associate (Discovery Antibacterials, Molecular Sciences )
Employment
Source: Self-asserted source
Elizabeth W. Sorensen

Pfizer Global Research and Development: Groton, CT, US

2002-05 to 2002-08 | Summer Associate (Discovery Immunology, Biology )
Employment
Source: Self-asserted source
Elizabeth W. Sorensen

Education and qualifications (3)

University of Rochester: Rochester, NY, US

2006-04 to 2010-06 | PhD (Department of Immunology, Microbiology, and Virology)
Education
Source: Self-asserted source
Elizabeth W. Sorensen

University of Rochester: Rochester, NY, US

2003-09 to 2006-04 | MS (Department of Immunology, Microbiology, and Virology)
Education
Source: Self-asserted source
Elizabeth W. Sorensen

Oberlin College: Oberlin, OH, US

1999-09 to 2003-05 | B.A. (Biology)
Education
Source: Self-asserted source
Elizabeth W. Sorensen

Professional activities (1)

American Association of Immunologists: Md., Md., US

2010 to present | Professional
Membership
Source: Self-asserted source
Elizabeth W. Sorensen

Works (7)

CXCL10 stabilizes T cell-brain endothelial cell adhesion leading to the induction of cerebral malaria.

JCI insight
2018-04-19 | Journal article
DOI: 10.1172/jci.insight.98911
PMID: 29669942
PMC: PMC5931132
Source: Self-asserted source
Elizabeth W. Sorensen

Splenic differentiation and emergence of CCR5+CXCL9+CXCL10+ monocyte-derived dendritic cells in the brain during cerebral malaria.

Nature communications
2016-11-03 | Journal article
DOI: 10.1038/ncomms13277
PMID: 27808089
PMC: PMC5097164
Source: Self-asserted source
Elizabeth W. Sorensen

Local expression of interleukin-2 by B16 melanoma cells results in decreased tumour growth and long-term tumour dormancy.

Immunology
2013-03 | Journal article
PMC: 3573281
Source: Self-asserted source
Elizabeth W. Sorensen

CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation.

Immunity
2012-11-01 | Journal article
DOI: 10.1016/j.immuni.2012.08.016
PMID: 23123063
PMC: PMC3525757
Source: Self-asserted source
Elizabeth W. Sorensen

IL-12 suppresses vascular endothelial growth factor receptor 3 expression on tumor vessels by two distinct IFN-gamma-dependent mechanisms.

Journal of immunology (Baltimore, Md. : 1950)
2010-01-08 | Journal article
DOI: 10.4049/jimmunol.0903210
PMID: 20061409
PMC: PMC3070472
Source: Self-asserted source
Elizabeth W. Sorensen

Omental immune aggregates and tumor metastasis within the peritoneal cavity.

Immunologic research
2009-02-28 | Journal article
DOI: 10.1007/s12026-009-8100-2
PMID: 19253004
PMC: PMC2891204
Source: Self-asserted source
Elizabeth W. Sorensen

Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity.

Journal of immunology (Baltimore, Md. : 1950)
2008-03-01 | Journal article
DOI: 10.4049/jimmunol.180.5.3132
PMID: 18292536
Source: Self-asserted source
Elizabeth W. Sorensen
How many people are using ORCID?